NAFLD: A Healthy lifestyle improves fatty liver in Type 2 Diabetes

被引：0
|
作者：
Kantartzis, Konstantinos [1 ]
机构：
[1] Univ Klinikum Tubingen, Tubingen, Germany
来源：
DIABETOLOGIE UND STOFFWECHSEL | 2011年 / 6卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：27 / 27
页数：1
相关论文
共 50 条
  • [1] Liraglutide Improves NAFLD in Patients with Type 2 Diabetes
    Basu, Debasis
    Chaudhuri, Soumyabrata Roy
    Deka, Nilakshi
    DIABETES, 2020, 69
  • [2] Characteristics of Patients with Type 2 Diabetes without Nonalcoholic Fatty Liver Disease (NAFLD)
    Saenz, Enrique Valdez
    Leiva, Eddison Godinez
    Lomonaco, Romina
    Marangi, Stephen A.
    Kalavalapalli, Srilaxmi
    Gonzalez, Maria A.
    Chi, Xiaofei
    Rocha, Andrea Ortiz
    Mohseni, Yasmine
    Barb, Diana
    Gurka, Matthew J.
    Sharma, Anu
    Cusi, Kenneth
    DIABETES, 2023, 72
  • [3] Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in patients with Type 2 Diabetes Mellitus
    Paola Portillo-Sanchez
    Kenneth Cusi
    Clinical Diabetes and Endocrinology, 2 (1):
  • [4] Impact of lifestyle modification on nonalcoholic fatty liver with prediabetes and type 2 diabetes
    Lindarto, Dharma
    Darmadi, Darmadi
    Sazli, Brama Ihsan
    RAWAL MEDICAL JOURNAL, 2024, 49 (01): : 199 - 203
  • [5] FOCUS ON THE TYPE 2 DIABETES PATIENT WITH LIVER DISEASE: EMPHASIS ON NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Cusi, Kenneth
    ENDOCRINE PRACTICE, 2011, 17 : 9 - 13
  • [6] Multidisciplinary intensive lifestyle intervention improves markers of nonalcoholic fatty liver disease (NAFLD) in patients with type 1 diabetes and obesity: a retrospective matched-cohort study
    Shaheen Tomah
    Tareq Salah
    Marwa Al-Badri
    Shilton Dhaver
    Hannah Gardner
    Mhd Wael Tasabehji
    Osama Hamdy
    Clinical Diabetes and Endocrinology, 9 (1):
  • [7] NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Bawany, Muhammad Adnan
    Lashari, Naveed Aslam
    Soomro, Majid Ali
    Memon, Hamid Nawaz Ali
    Laghari, Fiza
    Irshad, Muntaha
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (07): : 6283 - 6286
  • [8] Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes
    Pennisi, Grazia
    Enea, Marco
    Falco, Vincenzo
    Aithal, Guruprasad P.
    Palaniyappan, Naaventhan
    Yilmaz, Yusuf
    Boursier, Jerome
    Cassinotto, Christophe
    de Ledinghen, Victor
    Chan, Wah Kheong
    Mahadeva, Sanjiv
    Eddowes, Peter
    Newsome, Philip
    Karlas, Thomas
    Wiegand, Johannes
    Wong, Vincent Wai-Sun
    Schattenberg, Joern M.
    Labenz, Christian
    Kim, Won
    Lee, Myoung Seok
    Lupsor-Platon, Monica
    Cobbold, Jeremy F. L.
    Fan, Jian-Gao
    Shen, Feng
    Staufer, Katharina
    Trauner, Michael
    Stauber, Rudolf
    Nakajima, Atsushi
    Yoneda, Masato
    Bugianesi, Elisabetta
    Younes, Ramy
    Gaia, Silvia
    Zheng, Ming-Hua
    Camma, Calogero
    Anstee, Quentin M.
    Mozes, Ferenc E.
    Pavlides, Michael
    Petta, Salvatore
    HEPATOLOGY, 2023, 78 (01) : 195 - 211
  • [9] GENE HEALTHY LIFESTYLE INTERACTIONS IN TYPE 2 DIABETES
    Franks, P. W.
    ANNALS OF NUTRITION AND METABOLISM, 2013, 63 : 28 - 29
  • [10] Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD)
    Cuthbertson, Daniel J.
    Koskinen, Juha
    Brown, Emily
    Magnussen, Costan G.
    Hutri-Kahonen, Nina
    Sabin, Matthew
    Tossavainen, Paivi
    Jokinen, Eero
    Laitinen, Tomi
    Viikari, Jorma
    Raitakari, Olli T.
    Juonala, Markus
    ANNALS OF MEDICINE, 2021, 53 (01) : 1256 - 1264
12345